<DOC>
	<DOCNO>NCT00004828</DOCNO>
	<brief_summary>OBJECTIVES : I . Determine pharmacokinetics exogenous liothyronine administer child undergo modify Fontan procedure . II . Determine liothyronine supplementation dose counter fall serum liothyronine concentration provide great potential myocardial benefit modify Fontan procedure . III . Evaluate potential toxicity exogenous liothyronine administer child undergo modify Fontan procedure .</brief_summary>
	<brief_title>Liothyronine Children With Single Ventricle Congenital Cardiac Malformations Undergoing Fontan Procedure</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , placebo control , dose escalation study . Initially , patient randomize receive either 1 3 different dosage liothyronine placebo undergoing Fontan procedure . If unacceptable toxicity observe group , third dose level liothyronine add randomization . A total 7 patient enrol dose level . All randomize study drug administer continuous infusion 1 hour surgery . Cardiac function assess 5 day surgery .</detailed_description>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<mesh_term>Tricuspid Atresia</mesh_term>
	<criteria>Single ventricle congenital cardiac malformation Must undergo modify Fontan procedure No concurrent medication know interfere thyroid metabolism include propranolol amiodarone No hepatic dysfunction No renal dysfunction No preexisting thyroid dysfunction</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>June 1998</verification_date>
	<keyword>cardiovascular respiratory disease</keyword>
	<keyword>heart defect</keyword>
	<keyword>rare disease</keyword>
</DOC>